Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD52 Antikörper

Der Ratte Monoklonal Anti-CD52-Antikörper wurde für FACS und IP validiert. Er ist geeignet, CD52 in Proben von Maus zu detektieren.
Produktnummer ABIN1449230

Kurzübersicht für CD52 Antikörper (ABIN1449230)

Target

Alle CD52 Antikörper anzeigen
CD52

Reaktivität

  • 59
  • 21
  • 7
  • 5
  • 5
  • 2
  • 1
Maus

Wirt

  • 23
  • 21
  • 19
  • 2
Ratte

Klonalität

  • 53
  • 6
  • 3
Monoklonal

Konjugat

  • 36
  • 10
  • 7
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD52 Antikörper ist unkonjugiert

Applikation

  • 43
  • 25
  • 25
  • 18
  • 15
  • 14
  • 14
  • 10
  • 10
  • 5
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
Flow Cytometry (FACS), Immunoprecipitation (IP)

Klon

BTG-2G
  • Spezifität

    This antibody reacts with mouse CAMPATH-1/CD52.

    Aufreinigung

    Protein G agarose

    Immunogen

    Mouse IL-2R alpha-TGM splenocyte

    Isotyp

    IgG2a
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    PBS containing 50 % glycerol, pH 7.2. Contains no preservatives.

    Konservierungsmittel

    Without preservative

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Upon receipt, store (in aliqouts) at -20 °C.
  • Target

    CD52

    Andere Bezeichnung

    CD52 / CAMPATH-1

    Hintergrund

    CAMPATH-1, also known as CD52, is a heavily glycosylated, GPI-anchored protein expressed at high levels on almost all thymocytes, lymphocytes, monocytes, and macrophages. The function of CD52 is unknown. However, CD52 is an exceptionally good target for complement-mediated cell lysis and antibody-mediated cellular cytotoxicity. Humanized CAMPATH-1antibodies have been used therapeutically to effectively deplete lymphocytes in allogeneic bone marrow transplants, hematologic malignancies, and autoimmune diseases. Clinical trials suggest CAMPATH-1 antibodies are especially promising in the treatment of leukemia, non-Hodgkin lymphomas, and rheumatoid arthritis. The apparent size of CAMPATH-1 by SDS-PAGE is 25-29 kDa, however, the actual molecule is much smaller, ~ 8-9 kDa as confirmed by total structure analysis and mass spectrometry.Synonyms: CDw52, Cambridge pathology 1 antigen, Epididymal secretory protein E5, HE5

    Gen-ID

    23833

    NCBI Accession

    NP_038734

    UniProt

    Q64389
Sie sind hier:
Chat with us!